In this CE activity, expert faculty evaluate timely treatment modifications in patients with DME who have a suboptimal response to anti-VEGF therapy, including the incorporation of corticosteroid therapy, based on the latest real-world and clinical trial data.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
100% of listed courses are free
254 of 254 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Adolescent Medicine
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- Infectious Disease
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Infectious Diseases
- Practice Management & Ethics
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Rheumatology
- Rhinology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedDec 1, 2025
-
Last day to claim creditDec 1, 2026 7 weeks left
-
Vindico Medical Education, LLC DME: Addressing Suboptimal Response and Expanding Therapeutic Strategies
-
Vindico Medical Education, LLC Diabetic Macular Edema: Rethinking Response and Revising Treatment With Corticosteroid Therapy
-
Vindico Medical Education, LLC Updates from ASRS: nAMD, DME/DR, and RVO Treatment
-
Answers in CME Inc. (AiCME) Bridging Clinical Trial and Real-World Evidence in Retinal Diseases: Updated Strategies With Anti-VEGF Therapies
-
Physicians’ Education Resource (CME Track) Rapid Reviews in Retina(TM): Emerging Updates from Winter 2026 – Addressing the Wealth of New Data in Treatments for nAMD, DME, and RVO
-
Impact Education +1 Virtual Journal Club: Best Practices in Payer Coverage and Utilization Management of Anti-VEGF Therapies for AMD and DR/DME enduring
